OT 20 (Mycapssa 20 mg)
Generic Name: octreotide
Pill with imprint OT 20 is White, Capsule-shape and has been identified as Mycapssa 20 mg.
Mycapssa is used in the treatment of acromegaly and belongs to the drug class somatostatin and somatostatin analogs. There is no proven risk in humans during pregnancy. Mycapssa 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for OT 20
Mycapssa
- Generic Name
- octreotide
- Imprint
- OT 20
- Strength
- 20 mg
- Color
- White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Somatostatin and somatostatin analogs
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Manufacturer
- Chiasma, Inc.
- National Drug Code (NDC)
- 69880-0120
Related Images for "OT 20"
More about Mycapssa (octreotide)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- Drug class: somatostatin and somatostatin analogs
- FDA Approval History
Consumer resources
- Other brands
- Sandostatin, Sandostatin LAR Depot, Bynfezia Pen
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.